---
title: "LabTech Holdings plans to transfer 6.15% of its company shares to Qingdao Innovation Investment"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/261889650.md"
description: "LabTech announced that LabTech Holdings intends to transfer 4.1455 million shares to Qingdao Innovation Investment at a price of 27.50 yuan per share, accounting for 6.15% of the total shares of the company. After the transfer, Qingdao Innovation Investment will become a shareholder holding more than 5%. This transfer will not affect the company's controlling shareholder and actual controller, nor will it trigger a takeover bid, and it will not have a significant impact on the company's governance structure and ongoing operations"
datetime: "2025-10-20T12:48:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/261889650.md)
  - [en](https://longbridge.com/en/news/261889650.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/261889650.md)
---

# LabTech Holdings plans to transfer 6.15% of its company shares to Qingdao Innovation Investment

According to the Zhitong Finance APP, LabTech (688056.SH) announced that on October 20, 2025, its shareholder holding more than 5% of the shares, LabTech Holdings, Inc. (referred to as "LabTech Holdings" or "Transferor"), signed a "Share Transfer Agreement" with Qingdao Innovation Investment Co., Ltd. (referred to as "Qingdao Innovation Investment" or "Transferee"). LabTech Holdings intends to transfer 4.1455 million unrestricted tradable shares of the company to Qingdao Innovation Investment at a price of 27.50 yuan per share, accounting for 6.15% of the total shares of the company. After the completion of this agreement transfer, Qingdao Innovation Investment will hold 4.1455 million shares of the company, accounting for 6.15% of the total shares, becoming a shareholder holding more than 5% of the company.

This agreement transfer will not lead to a change in the company's controlling shareholder or actual controller, will not trigger a tender offer, and will not have a significant impact on the company's governance structure and ongoing operations

### Related Stocks

- [688056.CN](https://longbridge.com/en/quote/688056.CN.md)

## Related News & Research

- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [India's lifeline ferry across strategic archipelago](https://longbridge.com/en/news/286716580.md)
- [TransThera Sciences to Raise HK$156 Million via Discounted H-Share Placement](https://longbridge.com/en/news/286833781.md)
- [Agnico Eagle CEO bets on Arctic barge shipping to keep costs low at Hope Bay gold mine](https://longbridge.com/en/news/287124816.md)
- [15:56 ETCrownPoint Partners Facilitates Sale of Exceptional Emergency Center & Micro Hospital in Lubbock, TX](https://longbridge.com/en/news/287110768.md)